Valsartan Tablet, Film Coated
Product Images NDC 51655-244

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 51655-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 244 52)

Label for Valsartan 160 mg film-coated tablets, USP, supplied in a package of 30 tablets. The label includes storage instructions (20°-25°C), warnings to keep out of reach of children and protect from moisture, and identifies Northwind Health Company, LLC as the labeler. The product is prescription-only.*

FDA Label Image

Valsartan Structural Formula (Image 05)

Chemical structure diagram of the active ingredient valsartan, depicting its molecular arrangement with labeled functional groups and bonds.*

FDA Label Image

Effects On Mortality Amongst Subgroups In Valiant (Image 06)

A forest plot comparing the effects of Valsartan versus Captopril across various patient subgroups. The horizontal axis ranges from 0.5 (favoring Valsartan) to 1.5 (favoring Captopril) with a central reference line at 1.0. The plot displays points and confidence intervals for subgroups including age, gender, race, geographic location, and beta-blocker use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.